Preclinical News and Research

RSS
Investment report on Rexahn Pharmaceuticals

Investment report on Rexahn Pharmaceuticals

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

Javelin Pharmaceuticals intends to terminate Merger Agreement with Myriad Pharmaceuticals

Javelin Pharmaceuticals intends to terminate Merger Agreement with Myriad Pharmaceuticals

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stress hormones may suppress tumor growth: Study

Stress hormones may suppress tumor growth: Study

Angiochem to highlight oncology program data at 101st American Association for Cancer Research meeting

Angiochem to highlight oncology program data at 101st American Association for Cancer Research meeting

Carestream Molecular Imaging, OncoVision sign exclusive agreement for Albira PET/SPECT/CT imaging system

Carestream Molecular Imaging, OncoVision sign exclusive agreement for Albira PET/SPECT/CT imaging system

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

NexMed expands San Diego facilities to accommodate pre-clinical research services

NexMed expands San Diego facilities to accommodate pre-clinical research services

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Idera Pharmaceuticals' TLR antagonists exert anti atherogenic effects in preclinical model of atherosclerosis

Idera Pharmaceuticals' TLR antagonists exert anti atherogenic effects in preclinical model of atherosclerosis

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

Fate Therapeutics to acquire Ottawa biotechnology company Verio Therapeutics

ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer

ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer

Secretary of Health announces five health research grants to improve health of Pennsylvanians

Secretary of Health announces five health research grants to improve health of Pennsylvanians

Aushon BioSystems introduces new multiplex biomarker Human Vascular Injury Panels

Aushon BioSystems introduces new multiplex biomarker Human Vascular Injury Panels

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Raptor Pharmaceutical engages The Trout Group for strategic advisory and investor relations services

Crucell, GSK sign agreement to develop 'second generation malaria vaccine'

Crucell, GSK sign agreement to develop 'second generation malaria vaccine'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.